Search bioRxiv⌕ Search

Biology subjects

SALAMA, P.

Publications and source records attributed to SALAMA, P..

2 recordsLinked to original sources

Multiscale Metabolic Covariance Networks Uncover Stage-Specific Biomarker Signatures Across the Alzheimer's Disease Continuum.

BackgroundConnectomics studies analyze neural connections and their roles in cognition and disease. Beyond regional comparisons, recent research has revealed inter-regional brain relationships via graph theory of brain network connectivity. Within these networks, path length measures a networks efficiency in communication. These connections can be quantified as inter-subject covariance networks related to functional connectivity, with alterations reported in neurodegenerative diseases. MethodsRetrospective analysis of ADNI 18F-FDG PET images using metabolic covariance analysis and hierarchical clustering was used to assess regional brain networks in subjects from cognitively normal (CN) to AD. We evaluated AD stage changes by calculating whole brain entropy, connection strength, and clustering coefficients. Additionally, estimates of shortest path for positive and negative correlations as a measure of network efficiency. We also developed a novel region set enrichment analysis (RSEA) to detect brain functional changes based on metabolic variations. Results were aligned with transcriptomic signatures and clinical cognitive assessments. FindingsIn AD subjects, whole brain metabolic connectivity revealed an increase in entropy, connection strength, and clustering coefficients, which indicates brain network reorganization as compensatory mechanisms of pathological disruption. As AD advances, path lengths between brain regions decrease from CN to MCI; however, path lengths significantly increased in AD. RSEA indicated functional changes in motor, memory, language, and cognition functions related to disease progression. InterpretationMetabolic covariance analysis of whole brain, and regional connectomics, track with AD progression. Moreover, path lengths permitted AD stages determination via alterations in brain connectivity. Furthermore, RSEA facilitated the identification of functional changes based on metabolic readouts. FundingNIH grant T32AG071444

neuroscience↗

Neuro-Metabolic and Vascular Dysfunction as an Early Diagnostic for Alzheimer's Disease and Related Dementias.

Alzheimers disease (AD) is the most prevalent neurodegenerative condition characterized by significant cognitive decline. Recent studies suggest that the brain undergoes anatomical and functional restructuring, resulting in neuro-metabolic and vascular dysregulation (MVD) prior to amyloid-{beta} accumulation, which begins at an early age and leads to the onset of AD. Using a retrospective clinical population (N=403) of subjects with varying disease stages from the Alzheimers Disease Neuroimaging Initiative (ADNI), we identified that disease progression follows a stage-dependent MVD pattern, facilitating the identification of at-risk and resilient brain regions. Although each region progresses at a different pace, regions associated with memory, cognitive tasks, and motor function showed significant early dysregulation. These changes aligned with transcriptomics and cognitive signatures. This study underscores that MVD in brain regions varies by sex and disease stage, making it a sensitive tool for early AD diagnosis. Furthermore, this approach could improve patient monitoring, stratification, and therapeutic testing.

neuroscience↗